Safeguarding GP says NHS concerns over gender care were met with retaliation
Dr Sarah Redvers says she was not pushed out because of her views on gender, but because she raised patient safety alarms inside the NHS and refused to let them go unanswered. The safeguarding GP told an employment tribunal that she was accused of transphobia, subjected to a hostile investigation, and eventually driven from her post after flagging concerns about the assessment and prescribing practices surrounding children and young people questioning their gender identity.
Her account places a raw institutional conflict at the centre of a clinical issue that has already drawn wider scrutiny in Sussex. At stake was not a political argument, Redvers said, but whether vulnerable patients were receiving careful assessment before being prescribed puberty blockers and cross-sex hormones. In her telling, the system responded to the messenger rather than the message.
Redvers had been the named safeguarding GP for Sussex, a role that put her in contact with clinicians who were worried about patient safety. In July 2020, one doctor raised alarm about a patient who had been seen by an online clinic registered overseas and wanted a GP to take over prescribing testosterone to an 18-year-old female distressed about her gender. Another Brighton GP, Dr Sam Hall, also gave advice on such prescriptions. Redvers said her central concern was straightforward: Hall was recommending treatment for patients he had not assessed or met, while other GPs felt uncomfortable prescribing.
She took the complaint to NHS England and was advised to raise it as a whistleblower. An initial investigation did not uphold the concerns. Yet over the following months, other GPs contacted her with similar worries about the quality of assessments, the prescribing of puberty-blocking drugs and cross-sex hormones, and the absence of specialist supervision at the WellBN clinic where Hall was based.
The clinical issue at the heart of this dispute is difficult to ignore. Young people presenting with gender distress often have overlapping mental health, safeguarding and developmental needs, and the threshold for medication must be high when evidence is limited and the patients are still maturing physically and psychologically. A rushed or incomplete assessment can leave clinicians treating a symptom rather than understanding the full underlying risk profile.
Redvers said a second NHS investigation also failed to address the safety questions properly. Instead, she was told there was a “general worry” that there would be allegations of transphobia. Hall, who is a trans man and was born female, had publicly promoted an affirmative approach to care and was involved locally in plans for a Trans Health hub. The second review concluded there was no cause for concern and described one colleague whose persistent interest in the issue appeared disproportionate. Redvers understood that as a reference to herself.
She rejects any suggestion that her concerns were ideological. “It’s about medical assessment and treatment of patients, which is something we have to get right, particularly in this complex group of vulnerable patients,” she told the tribunal. She also described any accusation of transphobia as appalling, and said such claims were dangerous when they obscured the actual safeguarding issues.
One sentence captures the divide. The fight was never about labels; it was about whether clinicians were prescribing without enough evidence, supervision, or review.
The conflict escalated further in 2021, when Redvers referred Hall to the General Medical Council after a concern from local mental health services about the care of a vulnerable 15-year-old. Hall emailed Adam Doyle, then chief executive of NHS Sussex, saying he was being victimised and needed protection from repeated attempts to disrupt his career. Doyle initially denied to the tribunal that he knew Hall, but it emerged that the two had previously held several mentoring meetings.
The GMC investigation was not pursued. NHS Sussex instead launched an investigation into Redvers herself and brought in an external investigator. She described the process as a “brutal” four-hour interrogation, saying she was distressed, broke down during questioning, and later required months off sick and treatment for trauma. Other colleagues interviewed in that process also complained, and the NHS upheld most of their complaints. The investigation concluded that Doyle and the trust should apologise to Redvers and warned that the way she had been treated could have a broader negative impact on staff willingness to raise concerns.
This is where the organisational failure becomes impossible to separate from the clinical one. When a safeguarding officer believes patient risk is being overlooked, a punitive response can chill future whistleblowing across the service. In a setting where children and adolescents may be highly vulnerable, that silence has direct consequences at the bedside.
By 2023, after a grievance outcome and a public allegation of transphobia made by a trans campaigner during an NHS meeting, Redvers said she could no longer see a future in the organisation. She left her safeguarding role, convinced that the NHS had failed to support her. Separately, parents, school governors and social workers began raising concerns about WellBN and Hall.
A later NHS safety investigation, completed in June 2026, found that dozens of children, some as young as 13, had been inappropriately prescribed drugs at the WellBN practice. The report said 78 children may have been harmed after puberty-blocking drugs and cross-sex hormones were prescribed without proper checks. NHS England said that when concerns were escalated in 2023, national directors met an affected family directly and asked regional leads to begin formal investigations. Wider concerns followed, the practice was asked to stop providing a specialised prescribing service, and a further independent patient safety investigation was launched in 2025.
The timing of that finding lands hard against Redvers’ account. She had been raising alarms years earlier, and a later investigation pointed to the same practice failures she said had been ignored.
NHS Surrey and Sussex said some employment processes should have been handled differently and apologised to Redvers. NHS England said it was totally unacceptable that young people were placed at risk by practitioners delivering care the NHS had not commissioned. WellBN said it recognised the seriousness and sensitivity of the matters raised and that its priority remained compassionate, safe and effective care.
Redvers is still waiting for the tribunal judgment. Her case now turns on more than personal grievance. It asks whether the NHS can identify safeguarding failures in gender-related care without treating clinical concern itself as misconduct, and whether vulnerable young people are better protected when staff are able to raise alarms without fear of professional retaliation.